- Home
- SNT vs OKYO Comparison
SNT vs OKYO Comparison
Compare SNT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNT
- OKYO
- Stock Information
- Founded
- SNT 1965
- OKYO 2007
- Country
- SNT Canada
- OKYO United Kingdom
- Employees
- SNT N/A
- OKYO N/A
- Industry
- SNT Telecommunications Equipment
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SNT Telecommunications
- OKYO Health Care
- Exchange
- SNT Nasdaq
- OKYO Nasdaq
- Market Cap
- SNT 36.6M
- OKYO 38.2M
- IPO Year
- SNT 1993
- OKYO 2022
- Fundamental
- Price
- SNT $2.64
- OKYO $1.07
- Analyst Decision
- SNT
- OKYO Strong Buy
- Analyst Count
- SNT 0
- OKYO 1
- Target Price
- SNT N/A
- OKYO $7.00
- AVG Volume (30 Days)
- SNT 83.8K
- OKYO 131.4K
- Earning Date
- SNT 11-12-2024
- OKYO 11-22-2024
- Dividend Yield
- SNT N/A
- OKYO N/A
- EPS Growth
- SNT N/A
- OKYO N/A
- EPS
- SNT 0.05
- OKYO N/A
- Revenue
- SNT $34,455,000.00
- OKYO N/A
- Revenue This Year
- SNT N/A
- OKYO N/A
- Revenue Next Year
- SNT N/A
- OKYO N/A
- P/E Ratio
- SNT $52.60
- OKYO N/A
- Revenue Growth
- SNT 2.04
- OKYO N/A
- 52 Week Low
- SNT $1.08
- OKYO $0.81
- 52 Week High
- SNT $2.64
- OKYO $2.12
- Technical
- Relative Strength Index (RSI)
- SNT 92.07
- OKYO 46.47
- Support Level
- SNT $2.24
- OKYO $1.07
- Resistance Level
- SNT $2.50
- OKYO $1.30
- Average True Range (ATR)
- SNT 0.15
- OKYO 0.07
- MACD
- SNT 0.12
- OKYO -0.01
- Stochastic Oscillator
- SNT 100.00
- OKYO 9.62
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.